54 f
1d
Faculty
66A strength of the BBCB program is its broad combination of faculty interests and disciplines. 59 Faculty members are drawn from many departments in the Perelman School of Medicine, 5a from other schools in the University, and from affiliated local research institutes. 82 The faculty are unified by research that is quantitative, mechanistic, molecular; That is founded on principles of chemistry 74 and physics; By the development of advanced biophysical, biochemical and chemical methods and instrumentation; 7b By the training of graduate students in these areas of research and that more broadly aligns with the mission of BBCB. 9
33
5e
FACULTY ALPHABETICALLY:
20
|
e
|||||||||||||||||||||||||
| A | 3cB | 3cC | 3cD | 3cE | 3cF | 3cG | 3cH | 3bI | 3bJ | 3cK | 3bL | 3cM | 3cN | 3cO | 3cP | 2bQ | 3cR | 3cS | 3bT | 2bU | 3cV | 3cW | 2bX | 3bY | 3bZ | c
9 18 1 1 9 18 1 52 6b Caroline Bartman, Ph.D, Metabolic flux, metabolomics, isotope tracing, cancer, immunology
45 65 Tobias Baumgart, Ph.D, Biomembrane function: thermodynamics, dynamics and mechanics
56 5c Joseph A. Baur, Ph.D Molecular mechanisms of aging and caloric restriction
52 80 Shelley L. Berger, Ph.D, Role of adaptors in regulation of transcriptional activation in yeast and humans
83 Kara Bernstein, Ph.D DNA damage, repair and tumorigenesis
57 93 Ben E. Black, Ph.D, Chromosome segregation; chromatin structure; epigenetic centromere specification; hydrogen/deuterium exchange
5f 64 Andres Blanco, Ph.D, Epigenetics in normal and pathological (eg. cancerous) cells
6e Kahlilia Blanco, Ph.D , 42 epigenetics, mitochondrial properties, stroke pathophysiology
53 78 Kathleen Boesze-Battagalia, Ph.D, Degradative processes, phagocytosis and autophagy, cell homeostasis
34 6f Ewa Bomba-Warczak, Ph.D, Lifelong maintenance of mitochondrial networks in long-lived cells.
4c 5e Roberto Bonasio, Ph.D, Noncoding RNAs in chromatin biology and epigenetics.
8f Greg Bowman, Ph.D, Protein folding, structure and dynamics, simulations
52 65 Donita C. Brady, Ph.D, Cancer biology, signal transduction, and metal homeostasis.
55 6b Lawrence Brass, MD, Ph.D, Molecular basis for intracellular signaling in vascular biology
2f 6f George Burslem, Ph.D Protein Engineering, Chemical Biology, Post-translational Modifications
55 53 Theresa Busch, Ph.D, Photodynamic therapy, tumor microenvironment
52 59 Luca Busino, Ph.D, Mechanisms of protein ubiquitylation and degradation
9 18 6f Natali Chanaday 30 Communication in neurons, Neurotransmitters
6c Yi-Wei Chang Cyro-EM tomogrophy of cells
47 78 David Chenoweth, Ph.D, Development and application of synthetic methods for creating molecules that mimic 23 or interact with biomolecules.
56 5f Sara Cherry, Ph.D, Genetic and mechanistic studies of viral-host interactions
77 Crystal Conn, Ph.D 65 Cancer Biology, Adaptive Stress Responses, mRNA Translation, Drug targeting, Protein Homeostasis
52 6e David Cormode, Ph.D, Medical imaging, nanoparticles, contrast agents, cardiovascular disease
1 2e
1
4b
85
Cesar de la Fuente, Ph.D, Machine Biology, Synthetic Biology, Computational Biology, Microbiology, Bioengineering.
57
51
Roberto Dominguez, Ph.D, Actin cytoskeleton, structural biology
1
18
6e
Amelia Escolano, Ph.D,
4a
Immunology, antibody affinity maturation, rational design of vaccines
1
18
57
68
Michael Farwell, MD, Developing new imaging tools, oncological applications of imaging
3c
5e
Andrew Santiago Frangos, Ph.D, Mechanisms and applications of immune systems
1
18
1
4d
8d
Alessandro Gardini, Ph.D, Understanding the role of enhancers and noncoding RNAs in transcriptional regulation in mammals.
1
42
5c
Mark Goulian, Ph.D, Two-component signaling, bacterial regulatory circuits
4c
81
Roger Greenberg, MD, Ph.D, Basic DNA repair mechanisms that impact cancer etiology and therapy
4f
7b
Kushol Gupta, Ph.D, Structural biology of large macromolecular assemblies that regulate genetic information;
33
X-ray crystallography; small-angle scattering.
20
1
47
75
Erika Holzbaur, Ph.D, Molecular motor-driven dynamics of organelles along the cellular cytoskeleton
1
18
1
1
18
1
4c
65
Paul A. Janmey, Ph.D, Cytoskeleton, biopolymer mechanics, phosphoinositides
1
57
97
Kelly Jordan-Sciutto, Ph.D, Integrated Stress Response, Molecular mechanisms underlying neuronal loss in neurodegenerative disorders.
1
29
1
4e
9
6e
Rahul M. Kohli, MD, Ph.D, Enzymatic basis for heterogeneity in the immune system and pathogens;
3b
enzyme mechanisms, chemical biology, protein evolution
1
29
1
52
7b
Melike Lakadamyali, Ph.D We study cytoskeleton and nuclear organization with super-resolution microscopy.
44
75
Michael Lampson, Ph.D, Chromosome segregation in mitosis and meiosis, biosensors for mitotic kinase
36
6e
Mitchell Lazar, MD, Ph.D, Nuclear receptors and the transcriptional regulation of metabolism
55
52
Edward B. Lee, MD, Ph.D, Neuropathology Alzheimer's, ALS disease
55
7a
Mitchell Lewis, D.Phil. , Gene regulation; protein crystallography; structural basis of recognition
31
57
Carman Man-chung Li, Ph.D Hereditary cancers, Germline heterozygosity
40
60
Lan Lin, Ph.D RNA modifications (a.k.a "epitranscriptomics") in human diseases
39
80
Shawn C. Little, Ph.D, Transcription bursting dynamics; single molecule measurements; cell fate specification
52
6f
Kathy Fange Liu, Ph.D, The nature and mechanism of mRNA modification and its role in disease
a0
Damaris Lorenzo, Ph.D Molecular mechanisms of diseases of the nervous system, metabolic disorders
57
66
Kristen W. Lynch, Ph.D, Mechanism and consequences of regulated alternative splicing
1
29
54
59
Leyuan Ma, Ph.D, Protein Engineering, Chemical Biology, Immunotherapies
54
7a
Michael S. Marks, Ph.D, Molecular mechanisms of intracellular protein transport and organelle biogenesis
54
9e
Ronen Marmorstein, Ph.D, Epigenetics, Protein acetylation, MAPK signaling, Metabolism, Structural Biology, Enzymology, Inhibitor Development
8d
Megan Matthews, Ph.D Chemical biology and enzymology.
82
Mustafa Mir, Ph.D Imaging, single molecule dynamics of gene expression
5f
5e
Andrew Modzelewski, Ph.D , Retrotransposon activity, Endogenous Retroviruses
1
52
78
Vera Moiseenkova-Bell, Ph.D, Cryo-EM, structure and function of transient receptor potential channels.
1
52
5d
Kenji Murakami, Ph.D, Transcription initiation and regulation in eukaryote.
1
49
4c
Maureen E. Murphy, Ph.D Tumor suppressor proteins, Cancer
56
76
John I. Murray, Ph.D.,
64
Embryonic transcriptional regulation; fate specification; cell lineages; C. elegans; microscopy
1
22
1
20
1
4d
6d
E. Michael Ostap, Ph.D, Biochemistry of contractile proteins, biophysics of cell motility, and
2f
characterization of unconventional myosins
1
29
1
4b
4b
Amish Patel, Ph.D Predictive computational framework for
47
characterizing biomolecular hydration, interactions and assemblies
55
96
Trevor M. Penning, Ph.D, Structure-function of aldo-keto reductases; role in steroid hormone action and chemical carcinogenesis
47
71
E. James Petersson, Ph.D., Semi-synthesis of labeled proteins to probe and control conformation
76
Mecky Pohlschroder
37
Prokaryotic Cell Surface Biogenesis and Function.
51
79
Benjamin L. Prosser, Ph.D., Mechano-signaling in the heart, Therapies for neurodevelopmental disorders.
1
29
29
1
51
59
Arjun Raj, Ph.D, Systems biology; developmental biology; non-coding RNA
51
86
Ravinder Reddy, Ph.D, Sodium and oxygen-17 MR methods; multiple quantum and polarization transfer MR techniques
48
76
Elizabeth Rhoades, PhD, Functional and dysfunctional mechanisms of intrinsically disordered proteins
59
97
Manolis Roulis, PhD , Function and architecture of the mesenchymal microenvironment in tissue homeostasis, immunopathology and cancer
54
8f
Harvey Rubin, MD, Ph.D, Pathogenesis of dormancy in mycobacterium tuberculosis; biomolecular computation, and enzymology
1
29
1
55
7a
Brian M. Salzberg, Ph.D, Multiple-site optical recording; excitation-secretion coupling; neural networks
57
69
Jeffery G. Saven, Ph.D, Theory, simulation and design of proteins and folding molecules
52
61
Mark Sellmyer, MD, Ph.D Molecular Imaging, chemical biology, synthetic biology
30
8c
Nikolaos Sgourakis, Ph.D Chemical and structural biology. Biomedical imaging, nanotechnology and supramolecular assemblies
55
6d
Kim A. Sharp, Ph.D Theory and simulation of protein and nucleic acid structure and function
43
42
Yihui Shen, Ph.D Imaging and Systems Metabolism
57
68
Junwei Shi, Ph.D, Hepatocellular Carcinoma, epigenetic regulators, signal transduction
57
74
James Shorter, Ph.D, Regulation of neuropathogenic prions and amyloids by protein-remodeling factors,
19
molecular chaperones
84
Hongjun Song, Ph.D, Neurogenesis and Epigenetic/Epitranscriptomic
25
Mechanisms in the Nervous System
52
6a
Yuanquan Song, Ph.D, Studying the formation, maintenance and function of neural circuits
57
37
Adam J. Stevens, Ph.D, Cancer Biology
1
1
29
1
3e
57
Bin Tian, Ph.D RNA processing and metabolism in cancer and immunity.
32
62
Cornelius Taabazuing, Ph.D Innate immunity. Molecular mechanisms of cell death.
99
Aaron Timperman, Ph.D, Microfluidics, Nanofluidics, Proteomics, Lab on a chip
8a
Blanton Tolbert, Ph.D Molecular mechanisms of gene expression in RNA viruses,
27
transcriptional control of viruses
9b
Dirk Trauner, Ph.D Chemical Biology, Optigenetic Control
1
37
6d
Andrew Tsourkas, Ph.D Molecular imaging, drug delivery, nanotechnology, and biotherapeutics
7c
Andrey Tvardovskiy, Ph.D Chromatin, Proteomics, Aging
1
29
1
54
7a
Gregory D. Van Duyne, Ph.D, Structural biology; protein-protein interactions; x-ray crystallography
1
1
29
4f
Liling Wan, Ph.D
56
, Chromatin and its regulatory network, cancer biology and epigenetics.
85
P. Jeremy Wang, MD, Ph.D,
6d
Epigenetics in reproduction, spermatogonial stem cell self-renewal, silencing of transposable elements.
1
55
74
Felix W. Wehrli, Ph.D, MRI of biomaterials microstructure, mathematical modeling, image processing
56
76
Aalim Weljie, Ph.D, Circadian, sleep, environmental and cancer metabolism via metabolomics profiling
51
53
Kathryn E. Wellen, Ph.D, Cancer cell metabolism, nutrient sensing
57
5b
Elizabeth Railey White, MD, PhD, Molecular mechanism of anesthesia action
51
7a
Walter Witschey, Ph.D. Study of
44
cardiovascular disease using imaging and computational biology.
1
29
29
1
54
7c
Xiaolu Yang, Ph.D, Molecular mechanisms of apoptosis and how they may relate to cancer and other diseases.
1c
1
4d
68
Kenneth S. Zaret, Ph.D, Investigating transcription factor interactions with chromatin
71
Lijun Zhou, Ph.D,
5c
Nucleic Acid Chemistry, Non-Natural Nucleic Acids, Structural Biology, Artificial Cells
56
72
Zhaolan (Joe) Zhou, Ph.D, Epigenetic control of genome function in brain development and disease
5
© The Trustees of the University of Pennsylvania
11
1e
